DE69834193D1 - Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregaten - Google Patents
Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregatenInfo
- Publication number
- DE69834193D1 DE69834193D1 DE69834193T DE69834193T DE69834193D1 DE 69834193 D1 DE69834193 D1 DE 69834193D1 DE 69834193 T DE69834193 T DE 69834193T DE 69834193 T DE69834193 T DE 69834193T DE 69834193 D1 DE69834193 D1 DE 69834193D1
- Authority
- DE
- Germany
- Prior art keywords
- fibrilles
- disease
- protein aggregates
- amyloid
- aggregates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97113320 | 1997-08-01 | ||
EP97113320 | 1997-08-01 | ||
PCT/EP1998/004810 WO1999006838A2 (en) | 1997-08-01 | 1998-07-31 | Novel method of detecting amyloid-like fibrils or protein aggregates |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69834193D1 true DE69834193D1 (de) | 2006-05-24 |
DE69834193T2 DE69834193T2 (de) | 2007-04-19 |
Family
ID=8227164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69834193T Expired - Lifetime DE69834193T2 (de) | 1997-08-01 | 1998-07-31 | Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregaten |
Country Status (3)
Country | Link |
---|---|
AT (1) | ATE323288T1 (de) |
DE (1) | DE69834193T2 (de) |
WO (1) | WO1999006838A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6846640B2 (en) | 2002-04-30 | 2005-01-25 | Pharmacia & Upjohn Company | Time-resolved fluorescence assay for the detection of multimeric forms of A-beta 1-40 |
AU2015295441B2 (en) | 2014-07-29 | 2020-05-14 | Neurimmune Holding Ag | Human-derived anti-huntingtin (HTT) antibodies and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8516081D0 (en) * | 1985-06-25 | 1985-07-31 | Ciba Geigy Ag | Assay & purification of amyloid components |
US5234814A (en) * | 1989-06-01 | 1993-08-10 | Du Pont Merck Pharmaceutical Company | Diagnostic assay for alzheimer's disease |
WO1996012544A1 (en) * | 1994-10-19 | 1996-05-02 | The General Hospital Corporation | A DIAGNOSTIC ASSAY FOR ALZHEIMER'S DISEASE: ASSESSMENT OF Aβ ABNORMALITIES |
GB9701045D0 (en) * | 1997-01-18 | 1997-03-05 | Narang Harash K | Diagnosis of neuro-degenerative disorders |
-
1998
- 1998-07-31 DE DE69834193T patent/DE69834193T2/de not_active Expired - Lifetime
- 1998-07-31 AT AT98943817T patent/ATE323288T1/de not_active IP Right Cessation
- 1998-07-31 WO PCT/EP1998/004810 patent/WO1999006838A2/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ATE323288T1 (de) | 2006-04-15 |
DE69834193T2 (de) | 2007-04-19 |
WO1999006838A3 (en) | 1999-07-08 |
WO1999006838A2 (en) | 1999-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE491721T1 (de) | Zusammensetzung und verfahren zum nachweis von krankheiten in zusammenhang mit der bildung von amyloid-ähnlichen fibrillen oder protein- aggregaten | |
ES2170104T3 (es) | Inhibidores de la produccion de proteinas de beta-amiloide. | |
DE69227380D1 (de) | Verfahren zur bestimmung und behandlung von alzheimer-krankheit | |
DE69837015D1 (de) | Verfahren zur Stabilisierung und Messung von Troponinkomplexen | |
ATE300052T1 (de) | Verwendung von radioliganden zum screening von inhibitoren der herstellung von beta-amyloid peptiden | |
ATE420204T1 (de) | Verfahren zur detektion von erkrankungen | |
ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
DE60335552D1 (de) | Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen | |
ATE478062T1 (de) | Zusammensetzungen und verfahren zur in vivo abbildung von loeslichen beta-amyloid | |
DE59912716D1 (de) | Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür | |
ATE545658T1 (de) | Verfahren zur behandlung von synovialsarkom | |
DE69433243D1 (de) | Verwendunf von ApoE zum Binden von TAU und MAP2c Proteinen und zur Behandlung von Alzheimer's Krankheit | |
DE60035693D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
WO2002046767A3 (en) | Diagnosis and treatment of alzheimer's disease | |
DE69108439D1 (de) | Verfahren zur Bestimmung des Glykationsprozentsatzes eines bestimmten Proteins. | |
DE69834193D1 (de) | Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregaten | |
DE69505376D1 (de) | Alpha b crystallin zur verwendung in diagnose und therapie von autoimmunkrankheiten, besonders multipler skerose | |
DE69621837D1 (de) | Methoden zur feststellung von alzheimerscher krankheit | |
DE60144493D1 (de) | Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen | |
DE69734890D1 (de) | Rdgb-proteine | |
DE69839733D1 (de) | Mit syndekan interagierende proteine und deren verwendung | |
DE60041266D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
DE59908120D1 (de) | Funktionelle vitamin-d-derivate und verfahren zur bestimmung von 25-hydroxy- und 1alpha,25-dihydroxy-vitamin-d | |
DE60334200D1 (de) | Verfahren zur messung von neprilysinaktivität | |
DE69509157D1 (de) | Verfahren zur Dauerhaften Verformung von Keratinsubstanzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |